Contact Information
Company Information
Company
MiNA Therapeutics
Professional Summary
Robert Habib serves as CEO at MiNA Therapeutics. MiNA Therapeutics operates in the biotechnology sector with approximately 34.0 employees. The company is headquartered in London, England. MiNA Therapeutics generates annual revenue of 6000000.0. To date, MiNA Therapeutics has raised 90003344.0 in total funding, with the most recent round being Other.
Industry & Role Insights
-
•
MessageCEO tracks 381 executives in the biotechnology sector.
-
•
We have verified contacts for 2 executives at MiNA Therapeutics.
-
•
10,137 executive contacts are available in England.
-
•
Our database includes 201,468 c suite-level executives.
Technologies
Mimecast
Outlook
Gmail
Google Apps
Google Font API
YouTube
WordPress.org
Mobile Friendly
Google Maps
Bootstrap Framework
Basis
Remote
Keywords
gene activation
rna therapeutics
liver disease
drug discovery
rna activation
small activating rna
rnaa therapeutics
gene therapy
nucleic acid therapeutics
transcriptional activation
gene modulation
disease treatment
clinical trials
pre-clinical development
biopharmaceuticals
gene regulation
therapeutic proteins
hemoglobin disorders
sickle cell disease
beta thalassemia
immune modulation
cancer therapy
personalized medicine
innovative therapeutics
drug development
oligonucleotide therapies
clinical proof of concept
novel drug candidates
liposomal delivery
healthcare partnerships
therapeutic platforms
transcription factors
immunotherapy
translational medicine
cellular biology
biomedical research
collaborative research
clinical research
pharmacology studies
on-target mechanism
patient outcomes
target gene activation
bioinformatics platform
drug candidates
therapeutic areas
genetic medicine
cancer immunotherapy
rna technology
medical innovation
lead compounds
research collaboration
clinical pipelines
health care
health
wellness & fitness
hospital & health care
Related Executives
Outreach Guidance — biotechnology Sector
Technology executives make decisions on infrastructure, tooling, and partnerships. When reaching out to Robert Habib, lead with your value proposition relative to the stack they currently use. Generic pitches perform poorly; specific technical relevance is key.
Robert Habib's Position in the MessageCEO Database
- •Robert Habib is 1 of 2 verified executive contacts we track at MiNA Therapeutics.
- •365 verified executive contacts in biotechnology are in the MessageCEO database.
- •10,040 verified executive contacts in England are in the database.
- •6 verified contacts work at biotechnology companies in the 34.0 employee range (same size as MiNA Therapeutics).
Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.
Frequently Asked Questions
How do I reach Robert Habib directly?
Robert Habib's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at MiNA Therapeutics. Access direct contact info to skip gatekeepers and reach the decision maker.
What company does Robert Habib work for?
Robert Habib is CEO at MiNA Therapeutics, a company in the biotechnology sector with 34.0 employees. The company is based in London, England.
Can I pitch or sell to Robert Habib?
As CEO at MiNA Therapeutics, Robert Habib is a key decision-maker in the biotechnology sector. MessageCEO Pro gives you verified email to reach Robert Habib directly — ideal for B2B sales, partnerships, and executive recruiting.
What industry is Robert Habib in?
Robert Habib works in the biotechnology industry as CEO at MiNA Therapeutics. MessageCEO provides verified contact information for executives across all major industries.
Is Robert Habib's contact information verified?
Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Robert Habib's profile is kept up-to-date with the latest available information.
Last updated: July 31, 2026
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans